Herpesvirus recombinant poxvirus vaccine
CA 2014465 C · Owner: Health Research Incorporated · Inventors: Paoletti, Enzo
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
What is described is a recombinant poxvirus such, as vaccinia virus, fowlpox virus and canarypox virus containing foreign DNA from herpesvirus. In one embodiment the foreign DNA is expressed in a host by the production of a herpesvirus glycoprotein. In another embodiment the, foreign DNA is expressed in a host by the production of at least two, particularly two or three, herpesvirus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, the barrier of maternal immunity in a newborn offspring can be overcome or avoided.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 12, 1990 and granted June 15, 1999. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 12, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 12, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.